期刊文献+

基于网络药理学研究雷公藤抗肝癌的分子机制及初步验证 被引量:1

Study of the molecular mechanism of Tripterygium wilfordii inhibition of liver cancer based on network pharmacology and its preliminary verification
在线阅读 下载PDF
导出
摘要 基于中药系统药理学数据库与分析平台(TCMSP)筛选雷公藤抗肝癌的有效成分,采用GeneCards、OMIM、Drugbank、GEO等疾病数据库筛选差异性表达基因,找到相互映射的核心物质及靶点,构建药效成分-靶点(C-T)网络、蛋白互作网络(PPI),进行gene ontology(GO)和Kyoto encyclopedia of genes and genomes(KEGG)富集分析,获知其生物学机制,并利用分子对接技术和生物学实验进行验证。结果表明,雷公藤的主要药效成分为雷公藤甲素和雷公藤红素,PTGS2、CXCL8、TGFB1、STAT3等核心靶点主要富集于癌症及多条炎症因子的相关通路中,雷公藤甲素与PTGS2以及雷公藤红素与PTGS2、CXCL8、STAT3有着很强的结合活性,雷公藤甲素和雷公藤红素可以抑制PTGS2和STAT3蛋白的表达。以上结果表明,雷公藤可能作用于这些靶点,通过调控细胞的增殖和凋亡,发挥抗炎、调节免疫的作用,从而抑制肝癌的恶化。 Based on the traditional Chinese medicine system pharmacology database and analysis platform(TCMSP),the effective components of Tripterygium wilfordii against liver cancer have been screened.GeneCards,OMIM,Drugbank,GEO and other disease databases were used to screen differentially expressed genes,and the core substances and targets of mutual mapping were found.The pharmacodynamic componenttarget(CT)network and protein interaction network(PPI)were constructed.Gene ontology(GO)and Kyoto encyclopedia of genes and genomes(KEGG)enrichment analysis were performed to learn the biological mechanism,and molecular docking technology and biological experiments were used to verify it.The results showed that the main effective components of Tripterygium wilfordii are triptolide and celastrol.PTGS2,CXCL8,TGFB1,STAT3 and other core targets are mainly enriched in cancer and multiple inflammatory factor related pathways.Triptolide has strong binding activity with PTGS2,and celastrol has strong binding activity with PTGS2,CXCL8 and STAT3.Triptolide and celastrol can thus inhibit the expression of PTGS2 and STAT3 proteins.The above results show that Tripterygium wilfordii may act on these targets,and play an antiinflammatory and immunoregulatory role by regulating cell proliferation and apoptosis,thereby inhibiting the progression of liver cancer.
作者 刘澍 卢建东 吕祎彤 喻长远 熊国良 LIU Shu;LU JianDong;LV YiTong;YU ChangYuan;XIONG GuoLiang(Shenzhen Traditional Chinese Medicine Hospital,Shenzhen 518005;College of Life Science and Technology,Beijing University of Chemical Technology,Beijing 100029,China)
出处 《北京化工大学学报(自然科学版)》 CAS CSCD 北大核心 2021年第5期66-75,共10页 Journal of Beijing University of Chemical Technology(Natural Science Edition)
基金 国家自然科学基金(82174531) 深圳市科技项目(JCYJ20180507183842516)。
关键词 雷公藤 网络分析 分子对接 肝癌 作用机制 Tripterygium wilfordii Hook F. network analysis molecular docking liver cancer mechanism
作者简介 第一作者:刘澍,男,1995年生,硕士生;通信联系人:喻长远,E-mail:yucy@mail.buct.edu.cn;通信联系人:熊国良,E-mail:xionggl@163.com。
  • 相关文献

参考文献4

二级参考文献65

  • 1张杰,廖启顺,王兰琼.国内雷公藤红素药理作用及临床运用研究概况[J].中国民族民间医药,2005,14(3):128-132. 被引量:5
  • 2张克君,李德春,高焱明,杨金镛,张炳远.NF-κB、MMP-9与肝细胞肝癌浸润转移的实验研究[J].中华肝胆外科杂志,2006,12(10):691-694. 被引量:15
  • 3邬林泉,戈华平,罗志强,傅华群,蒋筱强.NF-κB与P-gP在肝细胞肝癌组织中的表达[J].中华肝胆外科杂志,2007,13(5):314-316. 被引量:6
  • 4张俊峰,陈规划,陆敏强,蔡常洁,杨扬,李华.线粒体在雷帕霉素诱导肝癌细胞Bel-7402凋亡中的作用[J].中国普外基础与临床杂志,2007,14(3):280-283. 被引量:2
  • 5Hsu YC, Wu CY, Lin IT. Hepatitis C virus infection, antiviral therapy, and risk of hepatoceltular carcinoma. Semin Oncol, 2015, 42(2): 329-338.
  • 6Dai Y, Desano J, Tang W, et al. Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progres- sion by modulating apoptotic proteins and NF-kappaB. PLoS One, 2010, 5(12): e14153.
  • 7Ji N, Li J, Wei Z, et al. Effect of celastrol on growth inhibition of prostate cancer cells through the regulation of hERG channel in vitro. Biomed Res Int, 2015, 2015: 308475.
  • 8Shrivastava S, Jeengar MK, Reddy VS, et al. Anticancer effect of celastrol on human triple negative breast cancer: Possible involve- ment of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways. Exp Mol Pathol, 2015, 98(3): 313-327.
  • 9Kim K. Interaction between HSP 70 and iNOS in skeletal muscle injury and repair. Journal of exercise rehabilitation, 2015, 11(5): 240-243.
  • 10Kim MN, Han KH, Ahn SH. Prevention of hepatoceUular carcinoma: beyond hepatitis B vaccination. Semin Oncol, 2015, 42(2): 316-328.

共引文献169

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部